Trials / Unknown
UnknownNCT02686853
Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis
Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis Without Acquired Immune Deficiency Syndrome
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Hui Bu · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to observe the clinical effect of intrathecal administration of liposomal amphotericin B in Cryptococcal Meningitis without Acquired Immune Deficiency Syndrome (AIDS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liposomal amphotericin B |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-01-01
- First posted
- 2016-02-22
- Last updated
- 2016-02-22
Source: ClinicalTrials.gov record NCT02686853. Inclusion in this directory is not an endorsement.